dexmedetomidine has been researched along with Acute Hepatic Failure in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Y; Liu, F; Liu, J; Meng, Z; Shen, W; Song, J; Song, P; Tong, F | 1 |
1 other study(ies) available for dexmedetomidine and Acute Hepatic Failure
| Article | Year |
|---|---|
Dexmedetomidine attenuates lipopolysaccharide-induced acute liver injury in rats by inhibiting caveolin-1 downstream signaling pathway.
Topics: Animals; Anti-Inflammatory Agents; Caveolin 1; Dexmedetomidine; Interleukins; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptor 4 | 2021 |